Dr. Stanislaw Burzynski, a Polish immigrant, was trained as both a biochemist and a physician. He’s spent the last 35 years developing and successfully treating cancer patients suffering with some of the most lethal forms of cancer at his clinic in Houston, Texas. The treatment he developed involves a gene-targeted approach using non-toxic peptides and amino acids, known as Antineoplastons.
After a grueling 15-year long battle, the Texas Medical Board has officially ended its crusade to revoke Dr. Stanislaw Burzynski’s medical license in an effort to end his use of Antineoplastons. The Texas Medical Board’s case against him was dismissed on November 19, 2012, just in time for Thanksgiving.
After it was revealed that the FDA had pressured the Texas medical board to revoke Dr. Burzynski’s medical license – despite the fact that no laws were broken, and his treatment was proven safe and effective – the obvious question was “why?” The answer to this has to do with money. Lots and lots of money… See, Dr. Burzynski owns the patent for this treatment, and should it actually gain FDA approval, not only would it threaten conventional chemotherapy and radiation, it would also result in billions of dollars of cancer research funds being funneled over to the one single scientist who has exclusive patent rights – Dr. Burzynski.
Dr. Burzynski received much-needed publicity two years ago with the release of ‘Burzynski: The Movie’. This documentary is about his remarkable cancer discovery, and how he won the largest and possibly the most convoluted and intriguing legal battle against the Food and Drug Administration (FDA) in American history. Soon afterward, the Texas Medical Board sued him again – without success.
This year, a second film detailing his continued struggles, and victories, is scheduled to be released. As announced in the trailer (see below), Dr. Burzynski is now doing the unthinkable…He is the first and only scientist in United States history to enter the federal drug approval process for a proprietary cancer therapy without any financial support from the American government, the pharmaceutical industry, or the cancer establishment.
November 29, 2012
Picking up where the first internationally award-winning documentary left off, “Burzynski: Cancer is Serious Business – Part 2” explores the the current status of clinical testing of Antineoplastons sanctioned by the Food & Drug Administration – as well as a modern story of patients being treated today at the Burzynski Clinic in Houston, Texas.
For most patients being treated by the Burzynski Clinic today – their advanced cancer itself runs secondary to the constant barrage of skepticism coming not only from their local oncologists – who simply do not understand Burzynski’s therapy – but also from their own friends and family who feel their loved ones are not making the correct treatment decisions – even though mainstream oncology has already left many of them for dead.
As this story unfolds, the audience will witness a real-time change of hearts and minds from many doctors and families.
Unlike the first documentary, we have interviewed board-certified oncologists, surgeons, and neurosurgeons for this film who witnessed their patients leave their care to return in great health, after opting for the Burzynski Clinic.
Since the mapping of the Cancer Genome, Burzynski has pioneered an expansion of his therapy that he calls, “Personalized Gene-Targeted Cancer Therapy”, where each patient’s Genomic Cancer Atlas is mapped, and a treatment regimen is personally tailored for each individual patient vs. the conveyor belt, “one size fits all” approach that current oncology adheres to. This part of the film will likely be the first time most of the audience will become aware of this new direction.
Due to the slow-moving bureaucratic obstacles of Antineoplastons by the FDA, this new expanded “personalized gene-targeted” direction has allowed more patients who are denied access to Antineoplastons by the FDA to benefit from Burzynski’s practice in ways never before thought possible.
This new personalized gene-targeted therapy isn’t without similar resistance and controversy that Antineoplaston therapy has since endured.
Visit the official site here: http://burzynskimovie.com/
to Pre-Order the DVD of new film, “Part II” shipping in July 2013.
The new 2-DVD Extended Edition Set of the original documentary is also available for purchase.